What This Means
This research suggests that a daily nutritional supplement containing a mix of gut-health and immune-supporting ingredients — including a postbiotic (heat-killed probiotic bacteria), a short-chain fatty acid (sodium butyrate), a prebiotic fiber, vitamin D, omega-3 fatty acid, quercetin, and a plant extract — may help improve symptom control in children who have both asthma and allergic rhinitis (hay fever-like symptoms). Over six months, children aged 5 to 12 who took the supplement showed meaningfully better scores on standardized tests measuring asthma control and nasal symptom burden compared to children who received a placebo. Children in the placebo group also needed more rescue medications during the study period.
Alongside these clinical improvements, laboratory experiments on immune cells (PBMCs) taken from the children before the study began showed that exposing those cells to the supplement ingredients reduced the production of inflammation-promoting immune signals (Th2 cytokines like IL-4, IL-5, and IL-13), increased an anti-inflammatory signal (IL-10), raised the proportion of regulatory T-cells (immune cells that help calm overactive immune responses), and activated genes associated with immune tolerance. This suggests the supplement may work by shifting the immune system away from the allergic inflammatory response.
Importantly, no side effects were reported, and more than 90% of participants adhered to the supplement regimen, suggesting it was well tolerated by children. However, this was a small exploratory pilot trial with only 40 participants at a single time point, so these findings are preliminary. Larger confirmatory trials would be needed to establish whether this type of supplement could become a reliable adjunctive approach for managing pediatric allergic asthma and rhinitis.